Recombinant KIR2DL2 (Lirilumab Biosimilar) 抗体
The Human 单克隆 anti-KIR2DL2 (Lirilumab Biosimilar) antibody (ABIN7538062) specifically detects KIR2DL2 (Lirilumab Biosimilar) in ELISA 和 WB.
The antibody is reactive with 人 samples.
产品编号 ABIN7538062
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant KIR2DL2 (Lirilumab Biosimilar) 抗体 (ABIN7538062)
抗原
KIR2DL2 (Lirilumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This KIR2DL2 (Lirilumab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade
-
产品特性
- Antibody Type: Human IgG1
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- KIR2DL2 (Lirilumab Biosimilar)
-
背景
- Lirilumab is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.
-
CAS-编号
- 1000676-41-4
抗原
-
You are here:
